Brian Cornblatt - Bioharvest Sciences Chief Officer
| CNVCF Stock | USD 5.13 0.07 1.35% |
Insider
Brian Cornblatt is Chief Officer of Bioharvest Sciences
| Phone | 604 622 1186 |
| Web | https://www.bioharvest.com |
Bioharvest Sciences Management Efficiency
The company has return on total asset (ROA) of (0.5264) % which means that it has lost $0.5264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (63.6438) %, meaning that it generated substantial loss on money invested by shareholders. Bioharvest Sciences' management efficiency ratios could be used to measure how well Bioharvest Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Armin Bieri | Aryzta AG PK | 59 | |
| Brady Millerberg | Aryzta AG PK | N/A | |
| Steven Gagnon | BioForce Nanosciences Holdings | 61 | |
| Justin OMeara | Avi Ltd ADR | 45 | |
| BCom BComm | The A2 Milk | 53 | |
| Paul Thompson | Premier Foods Plc | N/A | |
| Marcus Opitz | Aryzta AG PK | 62 | |
| Jamie Eichman | Laird Superfood | 46 | |
| Ronan Minahan | Aryzta AG PK | N/A | |
| John JankovichBesan | Avi Ltd ADR | 55 | |
| Simon BBusSci | Avi Ltd ADR | 60 | |
| Anya Hamill | Laird Superfood | 50 | |
| Richard Martin | Premier Foods Plc | N/A | |
| William Drury | Artisan Consumer Goods | 61 | |
| Martin Huber | Aryzta AG PK | 53 | |
| Roger Coppin | Avi Ltd ADR | 62 | |
| John LaViolette | BioForce Nanosciences Holdings | 62 | |
| David Hood | Avi Ltd ADR | 66 | |
| Keith Cooper | Aryzta AG PK | N/A | |
| Daryl Moore | Laird Superfood | N/A | |
| Amanda Hart | The A2 Milk | N/A | |
Management Performance
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 |
Bioharvest Sciences Leadership Team
Elected by the shareholders, the Bioharvest Sciences' board of directors comprises two types of representatives: Bioharvest Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioharvest. The board's role is to monitor Bioharvest Sciences' management team and ensure that shareholders' interests are well served. Bioharvest Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioharvest Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zaki Rakib, CoFounder Chairman | ||
| BCom BComm, Chief Officer | ||
| Brian Cornblatt, Chief Officer | ||
| David Ryan, S Relations | ||
| Yochi Hagay, CTO CoFounder | ||
| Ilan Sobel, Chief Officer |
Bioharvest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bioharvest Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.